Reviva Pharmaceuticals to Participate in the 2022 BIO International ConventionGlobeNewsWire • 06/02/22
Reviva Pharmaceuticals to Present at the H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 05/17/22
Reviva Pharmaceuticals Holdings, Inc. Reports First Quarter 2022 Financial Results and Recent Business HighlightsGlobeNewsWire • 05/16/22
Reviva Pharmaceuticals Announces Update on RECOVER, a Pivotal Phase 3 Global Study Evaluating Brilaroxazine for the Treatment of SchizophreniaGlobeNewsWire • 05/03/22
Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®GlobeNewsWire • 03/24/22
Reviva Pharmaceuticals Holdings, Inc. to Participate at the Maxim Virtual Growth ConferenceGlobeNewsWire • 03/22/22
Reviva Pharmaceuticals Holdings, Inc. to Present at Upcoming Virtual Investor ConferencesGlobeNewsWire • 03/18/22
Reviva Pharmaceuticals Holdings, Inc. Reports Full Year 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 03/15/22
Reviva Pharmaceuticals Announces First Patients Dosed in Pivotal Phase 3 Study and Long-Term Safety Trial Evaluating Brilaroxazine for the Treatment of SchizophreniaGlobeNewsWire • 02/01/22
Reviva Pharmaceuticals Holdings, Inc. Receives FDA May Proceed Letter for Pivotal Phase 3 Clinical Trial and Long-Term Safety Trial Evaluating Brilaroxazine For The Treatment of SchizophreniaGlobeNewsWire • 01/10/22
Reviva Pharmaceuticals to Participate in the Upcoming January Virtual Investor ConferencesGlobeNewsWire • 12/20/21
Reviva Pharmaceuticals Holdings, Inc. Reports Third Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 11/15/21
Reviva Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceGlobeNewsWire • 09/02/21
Reviva Pharmaceuticals Holdings, Inc. Reports Second Quarter 2021 Financial Results and Recent Business HighlightsGlobeNewsWire • 08/16/21
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10Benzinga • 07/26/21
Why Voyager Therapeutics, uniQure, Axsome, Reviva Pharma and Crispr Are Moving TodayBenzinga • 04/26/21